Log in to save to my catalogue

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive pa...

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive pa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3581597

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

About this item

Full title

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

Publisher

Ottawa, ON: Canadian Medical Association

Journal title

Journal of psychiatry & neuroscience, 2013-03, Vol.38 (2), p.98-106

Language

English

Formats

Publication information

Publisher

Ottawa, ON: Canadian Medical Association

More information

Scope and Contents

Contents

Background The dopamine (DA) D2 receptors exist in 2 states: a high-affinity state (D2high ) that is linked to second messenger systems, responsible for functional effects, exhibits high affinity for agonists (e.g., DA), and a low-affinity state that is functionally inert exhibits lower affinity for agonists. The DA D3 receptor subtype exhibits hig...

Alternative Titles

Full title

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3581597

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3581597

Other Identifiers

ISSN

1180-4882

E-ISSN

1488-2434

DOI

10.1503/jpn.110181

How to access this item